{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:12:24Z","timestamp":1747282344323,"version":"3.40.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.euroneuro.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T23:42:22Z","timestamp":1419032542000},"page":"435-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The chemical interaction between adrenochrome, three different classes of antipsychotic drugs and metabolites of the kynurenine pathway"],"prefix":"10.1016","volume":"25","author":[{"given":"Christine L.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.12.001_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1042\/bj0530620","article-title":"The association of zinc and other metals with melanin and a melanin-protein complex","volume":"53","author":"Bowness","year":"1953","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.12.001_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull"},{"issue":"5","key":"10.1016\/j.euroneuro.2014.12.001_bib3","first-page":"372","article-title":"Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro","volume":"63","author":"Buszman","year":"2008","journal-title":"Pharmazie"},{"issue":"2","key":"10.1016\/j.euroneuro.2014.12.001_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00249-005-0007-9","article-title":"Lipid membrane-induced optimization for ligand-receptor docking: recent tools and insights for the \u201cmembrane catalysis\u201d model","volume":"35","author":"Castanho","year":"2006","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.euroneuro.2014.12.001_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jat\/25.7.607","article-title":"3H-nicotine, 3H-flunitrazepam, and 3H-cocaine incorporation into melanin: a model for the examination of drug-melanin interactions","volume":"25","author":"Claffey","year":"2001","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.euroneuro.2014.12.001_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-2952(72)90270-5","article-title":"Interaction of chloropromazine with adrenochrome and interference of a possible endogenous psychotogenic agent with some synaptic enzyme activities","volume":"21","author":"Galzigna","year":"1972","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.12.001_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0003-9861(57)90246-1","article-title":"Tyrosinase-produced quinones and the disappearance of kynurenine in larval extracts of Drosophila melanogaster","volume":"67","author":"Glassman","year":"1957","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.euroneuro.2014.12.001_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9258(18)65348-7","article-title":"Mechanism of the catalytic oxidation of adrenaline by ferritin","volume":"220","author":"Green","year":"1956","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.euroneuro.2014.12.001_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1021\/cr50026a001","article-title":"The chemistry of adrenochrome and related compounds","volume":"59","author":"Heacock","year":"1959","journal-title":"Chem. Rev"},{"key":"10.1016\/j.euroneuro.2014.12.001_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1192\/bjp.100.418.29","article-title":"Schizophrenia. A new approach","volume":"100","author":"Hoffer","year":"1954","journal-title":"Part II. Ment. Sci"},{"key":"10.1016\/j.euroneuro.2014.12.001_bib11","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2005-03-1159","article-title":"Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS","volume":"106","author":"Kemna","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.euroneuro.2014.12.001_bib12","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.neuint.2008.01.013","article-title":"Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder","volume":"52","author":"Miller","year":"2008","journal-title":"Neurochem. Int."},{"issue":"2-3","key":"10.1016\/j.euroneuro.2014.12.001_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.schres.2009.05.014","article-title":"Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder","volume":"113","author":"Miller","year":"2009","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.12.001_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1570163811310030003","article-title":"On the mechanism of action of antipsychotic drugs: a chemical reaction not receptor blockade","volume":"10","author":"Miller","year":"2013","journal-title":"Curr. Drug Discov. Technol"},{"issue":"5","key":"10.1016\/j.euroneuro.2014.12.001_bib15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/schbul\/sbq083","article-title":"Antipsychotic dosing: how much but also how often?","volume":"36","author":"Remington","year":"2010","journal-title":"Schizophr. Bull"},{"issue":"6","key":"10.1016\/j.euroneuro.2014.12.001_bib16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0026-895X(25)12561-3","article-title":"Kinetics of binding of membrane-active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site","volume":"27","author":"Rhodes","year":"1985","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.euroneuro.2014.12.001_bib17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.npp.1301305","article-title":"Dopamine and serotonin receptor binding and antipsychotic efficacy","volume":"32","author":"Richtand","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.12.001_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1471-4159.1975.tb03887.x","article-title":"Melanin formation by human brain in vitro","volume":"24","author":"Rodgers","year":"1975","journal-title":"J. Neurochem."},{"issue":"16","key":"10.1016\/j.euroneuro.2014.12.001_bib19","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1073\/pnas.83.16.5774","article-title":"Membrane lipid phase as catalyst for peptide-receptor interactions","volume":"83","author":"Sargent","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"7","key":"10.1016\/j.euroneuro.2014.12.001_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.12.001_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1176\/appi.psy.43.5.354","article-title":"Cataract occurrence with antipsychotic drugs","volume":"43","author":"Shahzad","year":"2002","journal-title":"Psychosomatics"},{"key":"10.1016\/j.euroneuro.2014.12.001_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10298420290015827","article-title":"The adrenochrome hypothesis of schizophrenia revisited","volume":"4","author":"Smythies","year":"2002","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2014.12.001_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1600-0749.2003.00120.x","article-title":"Interference of some tryptophan metabolites in the formation of melanin in vitro","volume":"17","author":"Soddu","year":"2004","journal-title":"Pigment Cell Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2014.12.001_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000267016","article-title":"Mechanism of coloration of human lenses induced by near-ultraviolet-photo-oxidized 3-hydroxykynurenine","volume":"22","author":"Tomoda","year":"1990","journal-title":"Ophthalmic Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.12.001_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/17425255.2011.532787","article-title":"Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction","volume":"7","author":"Zhang","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14003356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T15:43:09Z","timestamp":1747237389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14003356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0924977X14003356"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.12.001","relation":{},"ISSN":["0924-977X"],"issn-type":[{"type":"print","value":"0924-977X"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The chemical interaction between adrenochrome, three different classes of antipsychotic drugs and metabolites of the kynurenine pathway","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}